Microba Life Sciences
Microba Life Sciences (ASX: MAP) is a Brisbane-based precision microbiome diagnostics company that sells clinical-grade gut microbiome testing (Microbiome Explorer Essentials, Extended and Comprehensive) to healthcare practitioners and their patients in Australia and the UK, using proprietary metagenomic sequencing and a 100%-coverage reference catalogue.
- Company typePublic
- Founded2017
- HeadquartersBrisbane, Australia
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Microba Life Sciences does
Microba Life Sciences (ASX: MAP) is a Brisbane-based precision microbiome diagnostics company that commercialises clinical-grade gut microbiome testing through a three-tiered product family — Microbiome Explorer Essentials, Extended, and Comprehensive — sold primarily via a practitioner-referral model to nutritionists, naturopaths, dietitians, integrative GPs, and functional medicine practitioners across Australia and the United Kingdom. The company combines metagenomic next-generation sequencing (mNGS), ELISA, and RT-PCR in a single integrated report, anchored by its proprietary Gut Microbiome Reference Catalogue (GMRC) covering 100% of known human gut microbiome species and a library of 75+ evidence-graded personalised insights grounded in 1,500+ peer-reviewed studies.
The underlying technology stack is run from a NATA-accredited (ISO 15189, plus ISO 13485 for bioinformatics) laboratory in Brisbane that produces interactive digital reports for both practitioners and patients; UK customer relationships and GDPR data-controller responsibilities are handled through the wholly-owned subsidiary Invivo Clinical Ltd (trading as Invivo Healthcare). Distribution is hybrid: direct sales through the practitioner portal and a 27-account enterprise channel in Australia, channel partnerships with Genova, Psomagen and Luminary for US test delivery, and a strategic global distribution alliance with Sonic Healthcare, which also holds approximately 20% equity following its November 2022 A$17.8M investment and an A$8.3M follow-on capacity commitment used to back the June 2026 capital raise.
Microba monetises on a per-test, one-time-license basis with optional practitioner- or patient-pay routing, supplemented by fees for expert interpretation consults. Q3 FY26 revenue of A$3.36M (up 62% year-over-year) and a 23,000+ annualized test run rate place the company in active scale-up mode, with management guiding to over 24,000 core tests for the full financial year and a targeted path to cashflow breakeven by end of CY2027 funded in part by a A$5M placement plus A$1M shareholder purchase plan completed in June 2026.
Microba Life Sciences firmographics
Firmographics- Name
- Microba Life Sciences
- Legal name
- Microba Pty Limited
- Website
- https://microba.com
- Company type
- Public
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Microba Life Sciences (ASX: MAP) is a Brisbane-based precision microbiome diagnostics company that sells clinical-grade gut microbiome testing (Microbiome Explorer Essentials, Extended and Comprehensive) to healthcare practitioners and their patients in Australia and the UK, using proprietary metagenomic sequencing and a 100%-coverage reference catalogue.
- Ownership category
- akta.pro rank
Microba Life Sciences industry classification
Industry- Product category
- Clinical Microbiome Diagnostics
- NAICS
- Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH)
- akta.pro secondary industries
- Microbiome & Metagenomics Services (HLAGANAH), Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)
Keywords
Where Microba Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Brisbane
- HQ country
- Australia
- HQ region
- Oceania
Offices3 records
Markets served
Microba Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Microbiome Testing Services: Revenue generated from clinical-grade microbiome testing services sold to healthcare practitioners who refer tests for their patients. Tests are ordered through a practitioner portal and results delivered via interactive digital reports with interpretation support.
- Clinical Support Services: Revenue includes fees for interpretation support, expert one-on-one case consults with microbiome specialists, and onboarding support services for practitioners.
Go-to-market motion4 records
Distribution channels5 records
Marketing channels7 records
Microba Life Sciences product offering
Product offeringCore offering
Microba delivers clinical-grade gut microbiome testing through the Microbiome Explorer product range (Essentials, Extended, Comprehensive), combining metagenomic next-generation sequencing, ELISA-based GI health markers, and RT-PCR pathogen screening in a single report. Tests are ordered by healthcare practitioners via a web portal and produce evidence-graded personalized insights on diet, lifestyle, and supplements backed by 1,500+ peer-reviewed studies. Samples are processed in an ISO 15189-accredited laboratory in Brisbane, Australia.
Product overview
Microba offers the Microbiome Explorer range, a three-tiered clinical-grade microbiome testing platform consisting of Essentials, Extended, and Comprehensive variants. The range combines multiple testing technologies (metagenomic next-generation sequencing, ELISA, and RT-PCR) in a single unified report. Essentials provides core microbiome profiling with 16 markers and 60+ insights; Extended adds 7 GI health markers for a total of 23 biomarkers with 75+ insights; Comprehensive is the full-featured offering combining all three technology panels with 40 biomarkers, 18 pathogen markers, and 75+ insights. All tests are supported by the Microba ClearCare Insights system, backed by 1,500+ peer-reviewed studies, and delivered through a practitioner portal with shareable digital reports.
Differentiator
Problem solved
Functional benefit
Brands
- Microbiome Explorer: Clinical-grade microbiome testing product range including Essentials, Extended, and Comprehensive tests using metagenomic next-generation sequencing technology.
Products and services
- Microbiome Explorer Essentials The essential-tier gut microbiome test using metagenomic next-generation sequencing, delivering 16 microbiome markers and 60+ evidence-graded personalized insights on diet, lifestyle, and supplements for patients' systemic health.
- Microbiome Explorer Extended The extended-tier test combining 16 metagenomic microbiome markers with 7 diagnostic GI health markers via ELISA technology, delivering 23 total biomarkers and 75+ evidence-graded insights for practitioners managing patients with gut and systemic health concerns.
- Microbiome Explorer Comprehensive The comprehensive gut microbiome test combining metagenomic next-generation sequencing (mNGS), ELISA-based GI health markers, and RT-PCR pathogen screening in one report, delivering 40 functional biomarkers, 18 pathogen markers, and 75+ evidence-graded personalized insights on diet, lifestyle, and supplements.
Quantifiable outcome
- 99% year-over-year revenue growth in Q3 FY26
- +4 more outcomes
Companies that use Microba Life Sciences
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles2 records
Microba Life Sciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Microba Life Sciences partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core, regional and minor.
- Invivo Clinical Ltd (Invivo Healthcare)coreInvivo Clinical Ltd manages UK customer relationships and distribution of microbiome testing services. Invivo is now part of Microba, combining Invivo's clinical practice and market presence with Microba's microbiome science and technology. Data controller for UK customers under UK GDPR.
- GenovaregionalGenova is Microba's US partner for test delivery, having launched Microbiomix - a legacy insight product. Collaboration enables US market access for Microba's testing technology.
- PsomagenminorMicroba has worked with Psomagen on US market implementation, similar to the Genova partnership arrangement.
- LuminaryminorMicroba has worked with Luminary on similar implementations for US market access.
Scale indicators10 records
Recent moves7 records
Expansion highlights5 records
Microba Life Sciences competitors and assessment
Company assessmentDirect peers
- Clinical Microbiomics (acquired by OraSure Technologies): Microbiome sequencing and bioinformatics services provider with deep expertise in shotgun metagenomics for clinical and research customers. Comparable to Microba in offering metagenomics-based microbiome analysis at clinical-grade quality for healthcare and research customers.
- ZOE: UK-based personalized nutrition company combining gut microbiome testing with continuous glucose monitoring and dietary analysis. Comparable to Microba as a UK-headquartered microbiome testing competitor addressing similar practitioner and consumer gut-health segments.
- DayTwo: Microbiome-based personalized nutrition company that translates gut microbiome profiles into food and glycemic recommendations. Comparable to Microba in combining clinical-grade microbiome testing with actionable dietary insights for chronic conditions (notably metabolic health).
- Viome: US-based direct-to-consumer and practitioner-focused gut microbiome testing company using metagenomic sequencing to deliver personalized nutrition insights. Comparable to Microba in core technology (mNGS-based gut microbiome profiling) and target end-users seeking personalized microbiome-driven recommendations.
- Genetic Analysis AS: Norwegian diagnostics company with the GA-map platform for gut microbiome dysbiosis testing, sold to clinicians and labs. Comparable to Microba as a clinical-grade microbiome diagnostics platform targeting similar clinical practitioner customers with dysbiosis-focused testing.
- Atlas Biomed: UK- and Russia-based microbiome and DNA testing company offering gut microbiome analysis with personalized health recommendations. Comparable to Microba in the European practitioner/consumer microbiome testing market and in using sequencing-based gut profiling.
- CosmosID: US-based microbial genomics company providing microbiome sequencing and bioinformatics services to researchers, food/feed companies, and clinical applications. Comparable to Microba in the underlying metagenomics and microbiome analytics technology stack, though oriented toward research/B2B rather than practitioner-referral testing.
- Map My Gut: UK-based practitioner-focused gut microbiome testing service combining DNA sequencing with practitioner-led interpretation. Comparable to Microba in serving the UK practitioner market with clinical microbiome testing and personalized recommendations.
- Thryve (now part of Sodexo/Care Innovation): Microbiome testing and insights platform that translates gut microbiome data into personalized health recommendations. Comparable to Microba in the gut microbiome testing category and in serving B2B health/wellness customers with personalized microbiome insights.
Broad incumbents
- Sonic Healthcare: Global medical diagnostics and laboratory services company that is both Microba's largest shareholder (~20%) and primary international distribution partner. Comparable as the incumbent clinical laboratory network through which Microba's tests reach global markets — though Sonic's portfolio is far broader than microbiome testing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Microba Life Sciences social profiles
Digital presenceMicroba Life Sciences compliance and trust
Trust signalCompliance4 records
Microba Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Microba Life Sciences leadership team
Management profileNumber of profiles
Profiles10 records
Microba Life Sciences subsidiaries and ownership
Company hierarchySubsidiaries1 record
Microba Life Sciences funding detail
Funding detailFunding overview
Funding rounds5 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Microba Life Sciences M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Microba Life Sciences
What does Microba Life Sciences do?
Microba delivers clinical-grade gut microbiome testing through the Microbiome Explorer product range (Essentials, Extended, Comprehensive), combining metagenomic next-generation sequencing, ELISA-based GI health markers, and RT-PCR pathogen screening in a single report. Tests are ordered by healthcare practitioners via a web portal and produce evidence-graded personalized insights on diet, lifestyle, and supplements backed by 1,500+ peer-reviewed studies. Samples are processed in an ISO 15189-accredited laboratory in Brisbane, Australia.
Is Microba Life Sciences a public or private company?
Microba Life Sciences is a public company. It is classified as public and is currently operating.
When was Microba Life Sciences founded?
Microba Life Sciences was founded in 2017. It employs 51 to 100 people.
Where is Microba Life Sciences based?
Microba Life Sciences is headquartered in Brisbane, Australia, in the Oceania region.
How does Microba Life Sciences make money?
Two revenue lines are on record. Microbiome Testing Services are the primary driver. The others are clinical Support Services.
Who are Microba Life Sciences's main competitors?
Direct peers on record are Clinical Microbiomics (acquired by OraSure Technologies), ZOE, DayTwo, Viome, Genetic Analysis AS, Atlas Biomed, CosmosID, Map My Gut and Thryve (now part of Sodexo/Care Innovation). Sonic Healthcare is listed as a broad incumbent.
Does Microba Life Sciences have an API?
No public API is recorded for Microba Life Sciences.
What industry is Microba Life Sciences in?
Microba Life Sciences's product category is Clinical Microbiome Diagnostics. Its primary akta.pro industry code is HLAAAFAH, Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal), with a secondary code of HLAGANAH, Microbiome & Metagenomics Services. Its NAICS code is 6215 and its SIC code is 8071.